Methylation of SRD5A2 Promoter Predicts a Better Outcome for Castration-Resistant Prostate Cancer Patients Undergoing Androgen Deprivation Therapy
PLoS ONE - United States
doi 10.1371/journal.pone.0229754
Full Text
Open PDFAbstract
Available in full text
Categories
Date
March 5, 2020
Authors
Publisher
Public Library of Science (PLoS)